Biosynthesis of Phosphatidyl Vitamin B6 by Phospholipase D Catalyzed Transphosphatidylation

Research Article

Austin Food Sci. 2016; 1(1): 1001.

Biosynthesis of Phosphatidyl Vitamin B6 by Phospholipase D Catalyzed Transphosphatidylation

Guo Z* and Xu X

Department of Engineering, Aarhus University, Denmark

*Corresponding author: Zheng Guo, Department of Engineering, Aarhus University, Denmark

Received: January 18, 2016; Accepted: January 30, 2016; Published: February 05, 2016

Abstract

Commercially available vitamin B6 (VB6) is the hydrochloric salt of pyridoxol, which is easily excreted with sweat and urea, therefore its bio-utilization rate is very low. PC (Phosphatidylcholine)-modified VB6 may change its transportation route, increase the membrane-affinity of VB6 and promote the assimilation of VB6. Phospholipase D (PLD) was thus used in this work to catalyze head group exchange of PC with pyridoxol yielding PC-VB6 derivative. The structure of the synthetic product was characterized by 1H & 13C NMR and HPLC-MS. Solvents were screened as organic phase of solvent/buffer reaction system; and dichloromethane was found to be a most suitable solvent to achieve the highest yield of phosphorylpyridoxol and least hydrolysis byproduct. Parameters considered important such as pH, reaction time, concentration of substrates, molar ratio of VB6/PC and enzyme loading were also investigated and evaluated; and up to 95% yield (mol %) of PC-VB6 could be achieved under optimized conditions. The results implied: 1) Soybean PC reacts faster than Dipalmitoylglycerophssphocholine (DPPC); 2) pH 5.6 is appropriate for PLD mediated transphosphatidylation of VB6; 3) Excessive VB6 (>15 fold of PC in mol is recommended) always leads to higher conversion of PC; 4) It takes 24h to reach equilibrium with 15-25 mM PC and 5-10U PLD/mL; 5) Synthetic PC-VB6 demonstrates a low enzymatic hydrolysis susceptibility.

Keywords: Pyridoxine (vitamin B6); Phosphatidylcholine (PC); Phospholipase D (PLD); Transphosphatidylation; Phospholipids

Introduction

Being the precursor of pyridoxal phosphate, Vitamin B6 functions as a highly versatile coenzyme in over 100 enzymatic reactions involved in the metabolism of amino acid, carbohydrates, neurotransmitters, and lipids, etc. [1,2]. Clinical evidence has also shown the physiological importance of VB6 in using as a glucocorticoid antagonist, alleviating menstrual irregularities and reducing weight gain with Depo-Provera, etc. [3-5]. There also is growing evidence the high levels of VB6 could suppress growth of cancer cells either in vivo or in vitro [6,7], which represents a new light to view the functionality of VB6. In practice, VB6 has been widely used as pharmaceutical, food supplement and antioxidant in cosmetic formulations [8]. Among three vitamers (pyridoxine, pyridoxamine and pyridoxal), pyridoxine is the main dietary and therapeutic form and usually administered as hydrochlorate. However, water-soluble pyridoxine hydrochlorate generally results in lower biological utilization because of a larger proportion of which excreted with sweat and urine. Lipophilic modification of water-soluble drugs has proved to be an efficient approach to modulate the properties of drugs and simultaneously ensure the cellular availability [9,10]. Because these lipophilic derivatives are supposed to exhibit long half-life but also to be easily distributed to hydrophobic microenvironment of target tissues, where the active ingredients are released by enzymatic interaction [11]. However, after pioneering work of Bbaldessari, et al. [12] who conduct lipase-catalysed esterification of VB6 with fatty acids, few reports concerning Vitamin B6 modification have been published so far. As the integral components of biomembranes, phospholipids not only play ubiquitous and fundamental function for life, but also provide a natural carrier for the delivery and modification of bioactive compounds [11,13,14]. Due to the structural similarity, phosphatidyl derivants are supposed to possess a high affinity to biomembranes and an easy accessibility to cells [13,14]. Phospholipase D (PLD, EC 3.1.4.4) catalyses the cleavage of the terminal phophodiester bond of glycerophopholipids through exchange of head group with water or various acceptor alcohols [15-17]. Thus, besides the hydrolysis resulting in phosphatidic acid, PLD can also serve as an efficient tool to catalyze the transfer of phosphatidyl moiety to the compounds with reactable hydroxyl groups, resulting in novel phospholipids [11,15- 18]. A great number of compounds with physiological or therapeutic activities, such as nucleosides [19], ascorbic acid [20], arbutin and kojic acid [21], have been investigated for transphosphatidylation. These modified products generally showed improved stability and beneficial usability. Structurally, VB6 is a polyfunctional derivative of pyridine, with 2 hydroxymethyl and 1 pheno-hydroxyl groups located at 4-, 5- and 3-position of pyridine ring, respectively (Figure 1). Therefore, it is theoretically feasible to prepare VB6 phosphatidyl derivants with catalysis of PLD. This novel VB6 derivants endow VB6 with different properties, which might help to explore innovative applications of this traditional drug.

To this end, this work presented a systematic study of PLDcatalyzed phosphatidylation of pyridoxine in two-phase system. The structure of the yield product was identified by GC-MS, H1 NMR and C13 NMR analysis. To establish an efficient protocol, reaction conditions involving solvent, enzyme efficiency, temperature and pH etc was optimized.

Materials and Methods

Materials

Phospholipase D (E.C. 3.1.4.4) Type VII from Streptomyces sp. (1550 units/mg solid) and 1,2-Dipalmitoyl-rac-glycero-3- Phosphocholine hydrate (DPPC) were purchased from Sigma- Aldrich (St. Louis, MO). Soybean phosphatidylcholine (with a minimum content 93%) was obtained from Degussa Texturant Systems Deutschland GmbH & Co.KG (Hamburg, Germany). The fatty acid composition (mol %) of soybean PC was C16:0, 13.7; C18: 0, 3.6; C18: 1, 9.5; C18: 2, 66.0; and C18: 3, 7.2. Pyridoxine (free base) was from Sigma-Aldrich Denmark A/S (Broendby, Denmark). Other chemicals and reagents were all of analytical grade and used as received.

Preparation of DPPC-Pyridoxine

10 m.mol pyridoxine was dissolved in 20 mL of 100 mM pH 5.6 sodium acetate buffer containing 40 mM Ca2+. The resulting solution was mixed with 20 mL dichloromethane of 1 mmol DPPC (0.734g). The reaction was initiated by the addition of 50 units of PLD dissolved in pH 5.6 NaOAc buffer (One unit is defined as the activity to liberate 1.0 μmole of choline from L-α-phosphatidylcholine (egg yolk) per hr at pH 5.6 at 30oC). The incubation was conducted at 30oC for 24 hr with magnetic stirring. At the end of the reaction, the organic layer was collected and washed 3 times with deionized water. The organic layer was then dried over anhydrous Na2SO4 and concentrated, and chromatographed on a silica gel column. The first elute with CHCl3- MeOH (3/1, v/v) yielded 637 mg DPPC-VB6. The elute with CHCl3- MeOH-H2O (10/5/1, v/v/v) gave 78.9 mg of recovered DPPC with little impurity of dipalmitoyl-3-phosphatidic acid salt.

Spectral analysis and structural identification

APCI LC/MS: The products and the PL standard mixture were separated on a silica column (l = 15 cm, i.d. = 4.6 mm, particle size = 5 μm, Phenomenex). The column was fitted into an HP 1100 Series LC/MSD system, consisting of a quaternary pump, a vacuum degasser, an autosampler, a diode array detector, and an MS detector (Hewlett-Packard, Waldbronn, Germany). A binary solvent system of chloroform/methanol/ ammonium acetate (90/10/0.5) and chloroform/methanol/water/ammonium acetate (60/35/5/0.5) was used. API-ES was used in the negative mode. The capillary voltage was 4000V, and the drying gas was 350oC and 10 L/min, nebulizer gas pressure was 25 psi. The heated nitrogen drying gas temperature and flow rate were 350oC and 4.0 L/min. Full mass spectra were taken in the mass range of 50 to 1000, and the step size was 0.1 m/z. System control and data evaluation were conducted by using HP ChemStation.

1H/13C NMR spectra were recorded with on a Bruker AVANCE III 400 MHz spectrometer using Tetramethylsilane (TMS) as internal standard in CDCl3-CD3OD (2:1, v/v).

Reaction optimization

To validate the commercial practicability of this approach, soybean lecithin was used for reaction optimization. Effects of traditional solvents, time, pH, concentration of PC and Vitamin B6, and enzyme efficiency were investigated, respectively. To facilitate comparison and evaluation, all performances were done under other identical or similar conditions. The conversion was indicated by the consumption of PC and the hydrolysis degree was expressed as the area percentage of PA in total phosphatidyl-based area from TLCFID data.

TLC-FID analysis

The samples from the reaction mixture was extracted by CHCl3- MeOH (3/1, v/v) and the resulting extract was washed with deionized water to remove pyridoxine. The TLC-FID analysis was performed on an Iatroscanner (Iatroscan MK6s, Iatron Laboratories, Tokyo, Japan) after the loaded samples were developed by solvent mixture of CHCl3-MeOH- H2O (50/20/3, v/v/v). PC-pyridoxine, PC and PA gave Rf of 0.71, 0.28 and 0.17, respectively. Area percentage was used as mass for the calculation of conversion of PC and yield of product.

Results and Discussion

Synthesis and characterization of DPPC-VB6

Preparation of DPPC-pyridoxine conjugates: To acquire a pure phosphatidyl derivative of pyridoxine for structural identification, DPPC has been used as a model PC to synthesize phosphatidyl VB6. The formation of a new product has been observed by the comparison of the TLC profiles of the reaction mixture before and after reaction (Figure 1). A new peak with Rf value at 0.71 excluding PC 0.28 and PA 0.17, as well as its time-dependent increase against the decrease of PC were observed. A typical time course monitored by TLC analysis was depicted in (Figure 2). As observed, the transphosphatidylation of DPPC to alcohol donor pyridoxol underwent a slow induction stage where the hydrolysis of DPPC into PA and transphosphatidylation of DPPC into PC-VB6 are almost equally in quantity. This probably can be ascribed the slow solublization of DPPC After 4h the transphosphatidylation increase linearly and becomes prevailing after 10h. The result seems suggested that 24 h is enough to maximize the reaction. Prolonging the reaction yields little beneficial effect on the preparation of DPP-VB6 rather more hydrolysis to PA.